inflammatory Bowel Disease - Microbiome Times Magazine

BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease

January 30, 2018 Microbiome Times

NESS ZIONA, Israel, Jan. 30, 2018 /PRNewswire/ — BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has exclusively sub-licensed from JSR Corporation a set of bacterial targets for the development and […]